MedTrace Logo

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

NCT06939634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-04-23

No results posted yet for this study

Summary

The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).

Conditions

  • Spinal Cord Injury
  • Tetraplegia/Tetraparesis
  • Paraplegia, Complete
  • Paraplegia, Incomplete
  • Guillain Barré Syndrome

Interventions

DEVICE

Hands-free exoskeleton

Having undergone at least on session with Atalante exoskeleton. Clinical, safety and session data are collected retrospectively.

Sponsors & Collaborators

  • Wandercraft

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06939634 on ClinicalTrials.gov